SEMMELWEIS UNIVERSITY, DEPARTMENT OF UROLOGY
TOPIC
Urology – Oncology
VISION
Precision medicine and individual molecular targeted therapy – a major breakthrough in oncology.
MISSION
To find biomarkers which can guide optimal therapy sequencing in prostate and bladder cancers.
SPECIFIC GOALS
- PROJECT 1: Different therapeutic sensitivity to abiraterone, enzalutamide and docetaxel in BRCA Positive Metastatic Castration-resistant Prostate Cancer Patients: a systematic review and meta-analysis.
- PROJECT 2: PARP Inhibitors have Comparable Efficacy to Platinum Chemotherapy in Patients with BRCA-Positive Metastatic Castration-resistant Prostate Cancer: a systematic review and meta-analysis.